Human Erythropoietin Quantikine IVD ELISA Kit

Product Details

Summary
Product Discontinued
View other related Erythropoietin/EPO ELISA Kits

Order Details


    • Catalog Number
      DEP00
    • Availability
      Product Discontinued

    Can't find what you are looking for? Use our Antibody Concierge Service & we will help you locate your antibody!

    Or feel free to contact us for alternative products.

Human Erythropoietin Quantikine IVD ELISA Kit Summary

Background
The Quantikine® IVD Human Epo ELISA is designed to measure Epo levels in serum or plasma in less than 4.5 hours (or less than 2.5 hours using the shaker protocol) for the quantitative determination of erythropoietin (Epo) concentration in human serum and plasma as an aid in the diagnosis of anemia and polycythemia. For in vitro diagnostic use.
Additional Information
For In Vitro Diagnostic Use
Specificity
Natural and recombinant human Epo
Source
N/A
Assay Type
Solid Phase Sandwich ELISA
Inter-Assay
See PDF Datasheet for details
Intra-Assay
See PDF Datasheet for details
Spike Recovery
See PDF Datasheet for details
Sample Volume
See PDF Datasheet for details
Gene
EPO

Applications/Dilutions

Dilutions
  • ELISA
Application Notes
Interference observed with other substances.
Publications
Read Publications using DEP00.

Packaging, Storage & Formulations

Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Human Erythropoietin Quantikine IVD ELISA Kit

  • ECYT5
  • EP
  • EPO
  • epoetin
  • Erythropoietin
  • MGC138142
  • MVCD2

Background

Erythropoietin (Epo), a glycoprotein (~30,400 Daltons) produced primarily by the kidney, is the principal factor regulating red blood cell production (erythropoiesis) in mammals. Renal production of Epo is regulated by changes in oxygen availability. Under conditions of hypoxia, the level of Epo in the circulation increases and this leads to increased production of red blood cells. 
The over-expression of Epo may be associated with certain pathophysiological conditions (1, 2). Polycythemia exists when there is an overproduction of red blood cells (RBCs). Primary polycythemias, such as polycythemia vera, are caused by Epo-independent growth of erythrocytic progenitors from abnormal stem cells and low to normal levels of Epo are found in the serum of affected patients. On the other hand, various types of secondary polycythemias are associated with the production of higher than normal levels of Epo. The overproduction of Epo may be an adaptive response associated with conditions that produce tissue hypoxia, such as living at high altitude, chronic obstructive pulmonary disease, cyanotic heart disease, sleep apnea, high-affinity hemoglobinopathy, smoking, or localized renal hypoxia (1, 2). In other instances, excessive Epo levels are the result of production by neoplastic cells. Cases of increased Epo production and erythrocytosis have been reported for patients with renal carcinomas (3), benign renal tumors (4), Wilms' tumors, hepatomas (5), liver carcinomas (6), cerebellar hemangioblastomas (3, 7, 8), adrenal gland tumors (9), smooth muscle tumors (3, 9), and leiomyomas (10). 
Deficient Epo production is found in conjunction with certain forms of anemias. These include anemia of renal failure and end-stage renal disease (1, 2, 11), anemias of chronic disorders [chronic infections (1), autoimmune diseases (1), rheumatoid arthritis (12), AIDS (13), malignancies (14)], anemia of prematurity (2), anemia of hypothyroidism (2), and anemia of malnutrition (2). Many of these conditions are associated with the generation of IL-1 and TNF-alpha , factors that have been shown to be inhibitors of Epo activity (1, 15). Other forms of anemias, on the other hand, are due to Epo-independent causes and affected individuals show elevated levels of Epo (2). These forms include aplastic anemias, iron deficiency anemias, thalassemias, megaloblastic anemias, pure red cell aplasias, and myelodysplastic syndromes.

Customers Who Viewed This Item Also Viewed...

203-IL
Species: Hu
Applications: BA
255-SC
Species: Hu
Applications: BA
NBP1-19388
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC,  IHC-P, Simple Western, WB
M6000B
Species: Mu
Applications: ELISA
7954-GM/CF
Species: Hu
Applications: BA
DVE00
Species: Hu
Applications: ELISA
MAB414
Species: Mu
Applications: ELISA(Cap), ELISA(Det), ELISA(Sta), Neut, WB
NBP2-59451
Species: Hu
Applications: ELISA, Flow, ICC/IF, MiAr, Simple Western, WB
2914-HT
Species: Hu
Applications: BA
7954-GM/CF
Species: Hu
Applications: BA
288-TPN/CF
Species: Hu
Applications: BA
MAB414
Species: Mu
Applications: ELISA(Cap), ELISA(Det), ELISA(Sta), Neut, WB
MAB1455
Species: Hu
Applications: CyTOF-ready, Dual ISH-IHC, ICC, IHC, ICFlow, Simple Western, WB
AF2168
Species: Hu, Mu
Applications: ChIP, Simple Western, WB
NB100-105
Species: Bv, Ca, Fe, Ma, Hu, Pm, Mu, Po, Pm, Rb, Rt, Sh, Xp
Applications: ChIP, ChIP, ELISA, Flow, GS, IA, IB, ICC/IF, IHC-FrFl, IHC, IHC-Fr,  IHC-P, IP, In vitro, KD, KO, LA, PLA, Simple Western, TCS, WB
AF4117
Species: Rt
Applications: IHC, WB
AF1584
Species: Hu, Mu
Applications: CyTOF-ready, ICC, IP, ICFlow, KO, Simple Western, WB
NLS3890
Species: Bv, Hu, Pm, Pm
Applications: IHC,  IHC-P
DEP00
Species: Hu
Applications: ELISA
⚠ WARNING: This product can expose you to chemicals including N,N-Dimethylforamide, which is known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.

Publications for Erythropoietin/EPO (DEP00)(79)

We have publications tested in 11 confirmed species: Human, Mouse, Rat, Chicken, Hamster, Plant - Nicotiana benthamiana, Primate - Macaca fascicularis (Crab-eating Monkey or Cynomolgus Macaque), Primate - Macaca mulatta (Rhesus Macaque), Primate - Papio anubis (Olive Baboon), Sheep, Transgenic Mouse.


Filter By Application
All Applications
Filter By Species
Human
(54)
Mouse
(9)
Rat
(2)
Chicken
(1)
Hamster
(1)
Plant - Nicotiana benthamiana
(1)
Primate - Macaca fascicularis (Crab-eating Monkey or Cynomolgus Macaque)
(6)
Primate - Macaca mulatta (Rhesus Macaque)
(4)
Primate - Papio anubis (Olive Baboon)
(1)
Sheep
(1)
Transgenic Mouse
(1)
All Species
Showing Publications 1 - 10 of 79. Show All 79 Publications.
Publications using DEP00 Applications Species
Navarro-Gonzales, P;Chavan, A;Wang, D;Burke, SK;Dykstra, K; A randomized trial to evaluate the pharmacokinetics, pharmacodynamics, and safety of vadadustat in patients with anemia associated with chronic kidney disease receiving hemodialysis BMC nephrology 2025-08-11 [PMID: 40790188] (Human) Human
Santos-Vizcaino, E;Virumbrales-Muñoz, M;Gonzalez-Pujana, A;Luker, GD;Ochoa, I;Hernandez, RM;Pedraz, JL; Genipin-crosslinked double PLL membranes overcome the strength-diffusion trade-off in cell encapsulation without compromising biocompatibility International journal of pharmaceutics 2025-01-10 [PMID: 39799997] (Mouse) Mouse
Odunze, U;Rustogi, N;Devine, P;Miller, L;Pereira, S;Vashist, S;Snijder, HJ;Corkill, D;Sabirsh, A;Douthwaite, J;Bond, N;Desai, A; RNA encoded peptide barcodes enable efficient in vivo screening of RNA delivery systems Nucleic acids research 2024-07-25 [PMID: 39051560] (Human, Mouse) Human, Mouse
Lee, Y;Jeong, M;Lee, G;Park, J;Jung, H;Im, S;Lee, H; Development of Lipid Nanoparticle Formulation for the Repeated Administration of mRNA Therapeutics Biomaterials research 2024-05-22 [PMID: 38779139] (Mouse) Mouse
Toro, L;Rojas, V;Conejeros, C;Ayala, P;Parra-Lucares, A;Ahumada, F;Almeida, P;Silva, MF;Bravo, K;Pumarino, C;Tong, AM;Pinto, ME;Romero, C;Michea, L; A Combined Biomarker That Includes Plasma Fibroblast Growth Factor 23, Erythropoietin, and Klotho Predicts Short- and Long-Term Morbimortality and Development of Chronic Kidney Disease in Critical Care Patients with Sepsis: A Prospective Cohort Biomolecules 2023-10-03 [PMID: 37892163] (Human) Human
MC Frise, DA Holdsworth, AW Johnson, YJ Chung, MK Curtis, PJ Cox, K Clarke, DJ Tyler, DJ Roberts, PJ Ratcliffe, KL Dorrington, PA Robbins Abnormal whole-body energy metabolism in iron-deficient humans despite preserved skeletal muscle oxidative phosphorylation Scientific Reports, 2022-01-19;12(1):998. 2022-01-19 [PMID: 35046429] (Human) Human
JT Royal, O Eiken, ME Keramidas, AC McDonnell, IB Mekjavic Heterogeneity of Hematological Response to Hypoxia and Short-Term or Medium-Term Bed Rest Frontiers in Physiology, 2021-12-14;12(0):777611. 2021-12-14 [PMID: 34975531] (Human) Human
C Cohen, S Coulon, K Bhukhai, A Neuraz, M Dussiot, G Fouquet, ML Stang, M Flamant, F Vrtovsnik, A Hummel, B Knebelmann, L Mesnard, E Rondeau, TT Maciel, F Favale, N Casadevall, T Nguyen-Kho, S Moutereau, C Legendre, M Benhamou, RC Monteiro, O Hermine, K El Karoui, IC Moura Erythrocytosis associated with IgA nephropathy EBioMedicine, 2021-12-24;75(0):103785. 2021-12-24 [PMID: 34959131] (Human, Mouse, Transgenic Mouse) Human, Mouse, Transgenic Mouse
A Raslan, J Ciriza, AM Ochoa de R, ML Sanjuán, MS Toprak, P Galvez-Mar, L Saenz-Del-, JL Pedraz Modulation of Conductivity of Alginate Hydrogels Containing Reduced Graphene Oxide through the Addition of Proteins Pharmaceutics, 2021-09-15;13(9):. 2021-09-15 [PMID: 34575549] (Human) Human
MC Man, C Ganera, GD B?rbule?, M Krzysztofi, AE Panaet, AI Cucui, DI Toh?nean, DI Alexe The Modifications of Haemoglobin, Erythropoietin Values and Running Performance While Training at Mountain vs. Hilltop vs. Seaside International Journal of Environmental Research and Public Health, 2021-09-08;18(18):. 2021-09-08 [PMID: 34574408] (Human) Human
Show All 79 Publications.

Reviews for Erythropoietin/EPO (DEP00) (0)

There are no reviews for Erythropoietin/EPO (DEP00). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for Erythropoietin/EPO (DEP00). (Showing 1 - 1 of 1 FAQs).

  1. What is the difference between the Quantikine and Duoset ELISA kits?
    • Our Quantikine kits are fully optimized and validated for the sample types listed on the product specific webpage and datasheet, as this can vary between kits. Each kit is supplied ready to use with one pre-coated 96-well plate, a detection antibody directly conjugated to HRP, and all other necessary reagents. These kits are ideal for researchers who want the convenience of a ready to use and optimized ELISA product. Some of these kits are also available prepackaged in larger 6 and 50 plate sizes.Our DuoSet Kits, in contrast, are ELISA development kits containing the capture and detection antibody, the mass-value calibrated standard, and streptavidin-HRP to prepare approximately 5 or 15 plates. Ancillary reagents will need to be used/purchased, and for most kits, we will recommend one of our Ancillary Reagent Kits, which contain the reagents we use ourselves in-house. DuoSet kits are validated only for cell culture supernatant samples and therefore require further development and validation for accurate measurement in more complex samples such as serum and plasma. Our DuoSet Kits offer an economical, flexible alternative for the experienced ELISA user.

Additional Erythropoietin/EPO Products

Blogs on Erythropoietin/EPO

There are no specific blogs for Erythropoietin/EPO, but you can read our latest blog posts.

Contact Information

Product PDFs

Review this Product

Be the first to review our Human Erythropoietin Quantikine IVD ELISA Kit and receive a gift card or discount.

Bioinformatics

Gene Symbol EPO